CEP Revision extends HAPILA Estriol API retest period to 60 months

News Releases

Find the latest News in

Home / News Releases

CEP Revision extends HAPILA Estriol API retest period to 60 months

CEP Revision extends HAPILA Estriol API retest period to 60 months

Thursday 23rd June 2022

By HAPILA GmbH Learn More >

MEDELPHARM My STYL’One webinar to focus on bilayer tablets

MEDELPHARM My STYL’One webinar to focus on bilayer tablets

Thursday 23rd June 2022

By MEDELPHARM Learn More >

New ‘human face’ for Charles Ischi to mark 30th Anniversary

Wednesday 22nd June 2022

By Charles Ischi… Learn More >

PSL bringing leading edge synthesis offering to IOPC oligo and peptide conference in Milan

PSL bringing leading edge synthesis offering to IOPC oligo and peptide conference in Milan

Tuesday 21st June 2022

By Peptide Specialty… Learn More >

Etihad Cargo Signs MOU with B Medical Systems for Sustainable Pharmaceutical Transportation Solutions

Etihad Cargo Signs MOU with B Medical Systems for Sustainable Pharmaceutical Transportation Solutions

Tuesday 21st June 2022

By B Medical… Learn More >

Bachem bringing advanced development and manufacturing offers to DDF 2022, Berlin

Bachem bringing advanced development and manufacturing offers to DDF 2022, Berlin

Friday 17th June 2022

By Bachem AG Learn More >

Cerbios-Pharma debuts as face-to-face presence at 11th Anniversary HPAPI Summit Boston

Cerbios-Pharma debuts as face-to-face presence at 11th Anniversary HPAPI Summit Boston

Thursday 16th June 2022

By CERBIOS-PHARMA SA Learn More >

Brinter® 3D bioprinter used to manufacture GBP gabapentin tablets for enhanced pet safety

Brinter® 3D bioprinter used to manufacture GBP gabapentin tablets for enhanced pet safety

Thursday 16th June 2022

By Brinter Ltd. Learn More >

Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances

Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances

Wednesday 15th June 2022

By Bachem AG Learn More >

Xzencis founder contributes to two Safety chapters in textbook on Translational Medicine

Xzencis founder contributes to two Safety chapters in textbook on Translational Medicine

Tuesday 14th June 2022

By Xzencis AB Learn More >

Bachem to present oligo purification advances at IOPC Milan

Bachem to present oligo purification advances at IOPC Milan

Monday 13th June 2022

By Bachem AG Learn More >

Cerbios nears completion of new cGMP cytotoxic unit for increased HPAPIs and Payloads production

Cerbios nears completion of new cGMP cytotoxic unit for increased HPAPIs and Payloads production

Friday 10th June 2022

By CERBIOS-PHARMA SA Learn More >